Effects of antidepressant drug imipramine on gene expression in rat prefrontal cortex

Neurochemical Research

Volumn 29, Issue 6, 2004, Pages 1235-1244

  Knuuttila, Juha E A ^a,b   Törönen, Petri ^b   Castrén, Eero ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antidepressants; cAMP; Microarray; Serine protease; SOM

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLIC AMP; IMIPRAMINE; MEMBRANE PROTEIN; SERINE PROTEINASE; NERVE PROTEIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC CODE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTSYNAPTIC MEMBRANE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTO ONCOGENE; RAT; REVIEW; SYNAPSE; UNINDEXED SEQUENCE; ALGORITHM; ANIMAL; ARTICLE; DRUG EFFECT; GENETICS; METABOLISM; ONCOGENE; PHYSIOLOGY; WISTAR RAT;

ANIMALIA;

ALGORITHMS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CYCLIC AMP; IMIPRAMINE; MALE; NERVE TISSUE PROTEINS; ONCOGENES; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SERINE ENDOPEPTIDASES;

EID: 3042702321     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000023610.89631.d6     Document Type: Review

References (64)

1. Skolnick, P. 1999. Antidepressants for the new millennium. Eur. J. Pharmacol. 375:31-40.
2. Nestler, E. J. 1998. Antidepressant treatments in the 21st century. Biol. Psychiatry. 44:526-33.
3. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., and Monteggia, L. M. 2002. Neurobiology of depression. Neuron 34:13-25.
4. Manji, H. K., Drevets, W. C., and Charney, D. S. 2001. The cellular neurobiology of depression. Nat. Med. 7:541-7.
5. Duman, R. S., Heninger, G. R., and Nestler, E. J. 1997. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 54:597-606.
6. Nibuya, M., Nestler, E. J., and Duman, R. S. 1996. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16:2365-72.
7. Thome, J., Sakai, N., Shin, K., Steffen, C., Zhang, Y. J., Impey, S., Storm, D., and Duman, R. S. 2000. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 20:4030-6.
8. Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., Ernfors, P., and Castrén, E. 2003. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23: 349-57.
9. Chen, A. C., Shirayama, Y., Shin, K. H., Neve, R. L., and Duman, R. S. 2001. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol. Psychiatry. 49:753-62.
10. Shaywitz, A. J. and Greenberg, M. E. 1999. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68:821-61.
11. Conti, A. C., Cryan, J. F., Dalvi, A., Lucki, I., and Blendy, J. A. 2002. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J. Neurosci. 22:3262-8.
12. Shieh, P. B. and Ghosh, A. 1999. Molecular mechanisms underlying activity-dependent regulation of BDNF expression. J. Neurobiol. 41:127-34.
13. Nibuya, M., Morinobu, S., and Duman, R. S. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15:7539-47.
14. Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., Gray, N. A., Zarate, C. A., Jr., and Charney, D. S. 2003. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry. 53:707-42.
15. Manji, H. K., Moore, G. J., and Chen, G. 2000. Lithium upregulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J. Clin. Psychiatry 61(Suppl 9):82-96.
16. Nestler, E. J., Kelz, M. B., and Chen, J. 1999. DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity. Brain Res. 835:10-7.
17. Hope, B. T., Nye, H. E., Kelz, M. B., Self, D. W., Iadarola, M. J., Nakabeppu, Y., Duman, R. S., and Nestler, E. J. 1994. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13:1235-44.
18. Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N., and Manji, H. K. 2000. Enhancement of hippocampal neurogenesis by lithium. J. Neurochem. 75:1729-34.
19. Malberg, J. E., Eisch, A. J., Nestler, E. J., and Duman, R. S. 2000. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20:9104-10.
20. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., and Hen, R. 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-9.
21. van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., and Gage, F. H. 2002. Functional neurogenesis in the adult hippocampus. Nature 415:1030-4.
22. Sheline, Y. I. 2003. Neuroimaging studies of mood disorder effects on the brain. Biol. Psychiatry 54:338-52.
23. Huang, N. Y., Strakhova, M., Layer, R. T., and Skolnick, P. 1997. Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex. J. Mol. Neurosci. 9:167-76.
24. Tohda, M., Qi, Z., and Watanabe, H. 1999. Influence of chronic treatment with imipramine on mRNA levels in rat brain: elevation of glyceraldehyde-3- phosphate dehydrogenase levels. Jpn. J. Pharmacol. 81:393-6.
25. Yamada, M., Yamada, M., Yamazaki, S., Takahashi, K., Nishioka, G., Kudo, K., Ozawa, H., Yamada, S., Kiuchi, Y., Kamijima, K., Higuchi, T., and Momose, K. 2000. Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain. Biochem. Biophys. Res. Commun. 278: 150-7.
26. Yamada, M., Yamada, M., Yamazaki, S., Takahashi, K., Nara, K., Ozawa, H., Yamada, S., Kiuchi, Y., Oguchi, K., Kamijima, K., Higuchi, T., and Momose, K. 2001. Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex. Neurosci. Lett. 301:183-6.
27. Hua, L. V., Green, M., Wong, A., Warsh, J. J., and Li, P. P. 2001. Tetraspan protein CD151: a common target of mood stabilizing drugs?. Neuropsychopharmacology. 25:729-36.
28. Landgrebe, J., Welzl, G., Metz, T., van Gaalen, M. M., Ropers, H., Wurst, W., and Holsboer, F. 2002. Molecular characterization of antidepressant effects in the mouse brain using gene expression profiling. J. Psychiatr. Res. 36:119-29.
29. Rausch, J. L., Gillespie, C. F., Fei, Y., Hobby, H. M., Stoming, T., Ganapathy, V., and Leibach, F. H. 2002. Antidepressant effects on kinase gene expression patterns in rat brain. Neurosci. Lett. 334: 91-4.
30. Andriamampandry, C., Muller, C., Schmidt-Mutter, C., Gobaille, S., Spedding, M., Aunis, D., and Maitre, M. 2002. Mss4 gene is upregulated in rat brain after chronic treatment with antidepressant and down-regulated when rats are anhedonic. Mol. Pharmacol. 62: 1332-8.
31. Yamada, M., Takahashi, K., Tsunoda, M., Nishioka, G., Kudo, K., Ohata, H., Kamijima, K., Higuchi, T., Momose, K., and Yamada, M. 2002. Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex. Pharmacogenomics J. 2:377-82.
32. Chen, B., Wang, J. F., Sun, X., and Young, L. T. 2003. Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells. Biol. Psychiatry 53:530-7.
33. Törönen, P., Wong, G., and Castrén, E. 2003. Methods for quantitation and clustering of gene expression data. Current Genomics 4:445-63.
34. Kontkanen, O., Törönen, P., Lakso, M., Wong, G., and Castrén, E. 2002. Antipsychotic drug treatment induces differential gene expression in the rat cortex. J. Neurochem. 83:1043-53.
35. Yang, Y. H., Dudoit, S., Luu, P., Lin, D. M., Peng, V., Ngai, J., and Speed, T. P. 2002. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30:e15.
36. Kohonen, T. 2001. Pages 85-144, The Basic SOM, in Huang, T. S., and Schoeder, M. R. (eds.), Self-organizing maps, 2nd ed., Springer, Berlin.
37. Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E. S., and Golub, T. R. 1999. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. USA. 96:2907-12.
38. Törönen, P., Kolehmainen, M., Wong, G., and Castrén, E. 1999. Analysis of gene expression data using self-organizing maps. FEBS Lett. 451:142-6.
39. Nikkilä, J., Törönen, P., Kaski, S., Venna, J., Castrén, E., and Wong, G. 2002. Analysis and visualization of gene expression data using self-organizing maps. Neural Netw. 15:953-66.
40. Boeckmann, B., Bairoch, A., Apweiler, R., Blatter, M. C., Estreicher, A., Gasteiger, E., Martin, M. J., Michoud, K., O'Donovan, C., Phan, I., Pilbout, S., and Sehneider, M. 2003. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 31:365-70.
41. Agresti, A. 1992. A survey of exact inference for contingency tables. Statistical Science 7:131-53.
42. Wong, S. and Walker, M. G. 2001. A bioinformatics approach to identifying fetal development genes. Gene Funct. Dis. 2: 221-5.
43. Wu, L. F., Hughes, T. R., Davierwala, A. P., Robinson, M. D., Stoughton, R., and Altschuler, S. J. 2002. Large-scale prediction of Saccharomyces cerevisiae gene function using overlapping transcriptional clusters. Nat. Genet. 31:255-65.
44. Draghici, S., Khatri, P., Martins, R. P., Ostermeier, G. C., and Krawetz, S. A. 2003. Global functional profiling of gene expression. Genomics 81:98-104.
45. Segal, E., Shapira, M., Regev, A., Pe'er, D., Botstein, D., Koller, D., and Friedman, N. 2003. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat. Genet. 34:166-76.
46. Hosack, D. A., Dennis, G., Jr, Sherman, B. T., Lane, H. C., and Lempicki, R. A. 2003. Identifying biological themes within lists of genes with EASE. Genome Biol. 4:R70.1-R70.8
47. Landgrebe, J., Wurst, W., and Welzl, G. 2002. Permutation-validated principal components analysis of microarray data. Genome Biol. 3: research0019.1-0019.11.
48. Nestler, E. J., Terwilliger, R. Z., and Duman, R. S. 1989. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53:1644-7.
49. Jensen, J. B., Shimon, H., and Mork, A. 2000. Abnormal protein phosphorylation in post-mortem brain tissue from bipolar patients. J. Neural Transm. 107:501-9.
50. Popoli, M., Gennarelli, M., and Racagni, G. 2002. Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord. 4:166-82.
51. Stewart, C. A. and Reid, I. C. 2002. Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission. Mol. Psychiatry 7:S15-22.
52. Martinez-Turrillas, R., Frechilla, D., and Del Rio, J. 2002. Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus. Neuropharmacology 43:1230-7.
53. Li, X., Tizzano, J. P., Griffey, K., Clay, M., Lindstrom, T., and Skolnick, P. 2001. Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 40:1028-33.
54. Beck, C. H. and Fibiger, H. C. 1995. Chronic desipramine alters stress-induced behaviors and regional expression of the immediate early gene, c-fos. Pharmacol. Biochem. Behav. 51:331-8.
55. Morinobu, S., Nibuya, M., and Duman, R. S. 1995. Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex. Neuropsychopharmacology 12:221-8.
56. Beck, C. H. 1995. Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain. J. Psychiatry Neurosci. 20:25-32.
57. Shirayama, Y., Chen, A. C., Nakagawa, S., Russell, D. S., and Duman, R. S. 2002. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22:3251-61.
58. Seidah, N. G. and Chretien, M. 1999. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848:45-62.
59. Meyer, A., Chretien, P., Massicotte, G., Sargent, C., Chretien, M., and Marcinkiewicz. M. 1996. Kainic acid increases the expression of the prohormone convertases furin and PC1 in the mouse hippocampus. Brain Res. 732:121-32.
60. Mowla, S. J., Farhadi, H. F., Pareek, S., Atwal, J. K., Morris, S. J., Seidah, N. G., and Murphy, R. A. 2001. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 276:12660-6.
61. Lee, R., Kermani, P., Teng, K. K., and Hempstead, B. L. 2001. Regulation of cell survival by secreted proneurotrophins. Science 294:1945-8.
62. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., and Weinberger, D. R. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-69.
63. Sklar, P., Gabriel, S. B., McInnis, M. G., Bennett, P., Lim, Y. M., Tsan, G., Schaffner, S., Kirov, G., Jones, I., Owen, M., Craddock, N., DePaulo, J. R., and Lander, E. S. 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neurotrophic factor. Mol. Psychiatry 7:579-93.
64. Neves-Pereira, M., Mundo, E., Muglia, P., King, N., Macciardi, F., and Kennedy, J. L. 2002. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 71:651-5.